Continuing Education Resource Center

Heparin-Induced Thrombocytopenia (HIT) from
Clinical Suspicion to Rapid Diagnosis, Lab Testing
and Implementation of HIT Testing Protocol

IL invites you to attend our Industry Workshop at the
69th AACC Annual Scientific Meeting and Clinical Lab Expo,
San Diego, CA

This workshop will be focused on detecting, testing and rapidly diagnosing Heparin-Induced Thrombocytopenia—a paradoxical and potentially devastating adverse drug reaction to heparin caused by the emergence of antibodies. The current management of HIT in US hospitals will
also be discussed, including the costs of HIT management.


  1. Review HIT as a clinical-pathologic syndrome
  2. Describe laboratory testing for HIT
  3. Discuss the clinical and cost impact of an on-demand Immunoassay for the Diagnosis of HIT
  4. Outline steps for implementing a HIT testing protocol


Theodore (Ted) E. Warkentin
Theodore (Ted) E. Warkentin, MD, FRCP, FACP
Prof. Dept. of Pathology/Molecular
Professor Dept. of Pathology/Molecular Medicine, and Dept. of Medicine, McMaster University; Regional Director, Transfusion Medicine, Hamilton Regional Laboratory Medicine Program; Hematologist, Service of Clinical
Hematology, Hamilton General Hospital

Hamilton, ON, Canada

Annie Winkler
Annie Winkler, MD, MSc

Director of Medical Affairs
Instrumentation Laboratory, Bedford, MA



© Instrumentation Laboratory 2018